Proactiveinvestors Australia

Antisense Therapeutics Ltd www.antisense.com.au/

Antisense Therapeutics Ltd (ASX:ANP) is an Australia-based company developing and commercialising antisense pharmaceuticals.

Pdf

Antisense Therapeutics Limited in ASX trading halt

Monday, March 07, 2016 by Proactive Investors

Antisense Therapeutics Limited is preparing to outline details in relation to the ATL1103 program for multiple sclerosis

Antisense Therapeutics Limited is preparing to outline details in relation to the ATL1103 program for multiple sclerosis

Antisense Therapeutics Limited (ASX:ANP) is preparing to outline details in relation to the ATL1103 program for multiple sclerosis.

Antisense has been granted a trading halt to prepare, with its shares placed in pre-open.

The halt will remain in place until the opening of trade on Wednesday 9th March 2016, or earlier if an announcement is made to the market.

 

Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

Sign up to Proactive Investors

Receive Proactive Investors Newsletter, Investor Forum Invites
Receive Proactive Investors Newsletter, Event Invites, Special Stock Notifications

Comments from Proactive Investors readers

  • Fill in your details below:
Verification Code


Copyright © proactiveinvestors.com.au, 2012. All Rights Reserved